Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial

enthalten in: Dermatology and therapy | 2023

von Kimball, A. | Prens, E. | Passeron, T. | +8